Sun Hee Kim

Crinetics Pharmaceuticals (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists”.

Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists

Bioorganic & Medicinal Chemistry Letters(2020)10.1016/j.bmcl.2020.127391

N/A

0DataRank · unranked

5 citations

Shimiao Wang, Sangdon Han, Sun Hee Kim, Ana Karin Kusnetzow, Julie Nguyen +6 more

TRAF6 and TAK1 contribute to SAMHD1-mediated negative regulation of NF-κB signaling

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.07.368704

N/A

0DataRank · unranked

1 citations

Corine St. Gelais, Serena Bonifati, Victoria Maksimova, Michael P. Cahill, Sun Hee Kim +2 more

Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist

ACS Medicinal Chemistry Letters(2022)10.1021/acsmedchemlett.2c00431

N/A

0DataRank · unranked

36 citations

Shimiao Wang, Stacy Markison, Sun Hee Kim, Sangdon Han, Mi Chen +9 more

Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism

Bioorganic & Medicinal Chemistry Letters(2022)10.1016/j.bmcl.2022.128807

N/A

0DataRank · unranked

2 citations

Shimiao Wang, Sun Hee Kim, Sangdon Han, Elizabeth Rico-Bautista, Emmanuel Sturchler +14 more